Fresenius pulls out of $4.3bn Akorn merger

23rd April 2018 Uncategorised 0

German healthcare firm Fresenius Kabi is walking away from a $4.3-billion merger with US generics group Akorn, claiming that the latter has failed to fulfill several closing conditions.

More: Fresenius pulls out of .3bn Akorn merger
Source: News